Gomis
@rgergom.bsky.social
📤 107
📥 44
📝 5
Eager for science, passion for arts... opinions are my own
reposted by
Gomis
IRB Barcelona
8 months ago
🧪Don't miss this webinar by Dr.
@rgergom.bsky.social
(#IRBBarcelona-#Inbiomotion) that explores the biology & mechanism of action of the MAF gene, shedding light on its significant impact on patient outcomes.
@sourcebioscience.bsky.social
#IRBBarcelona-#Inbiomotion)
https://youtu.be/M7bvPjPQCq0?feature=shared
#BreastCancer
loading . . .
Enjoy the videos and music that you love, upload original content and share it all with friends, family and the world on YouTube.
https://youtu.be/M7bvPjPQCq0?feature=shared
0
7
2
reposted by
Gomis
IRB Barcelona
9 months ago
📌 MetEND: Descodificando las dependencias entre la
#metástasis
y la vasculatura. El proyecto coordinado por el Dr.
@rgergom.bsky.social
pretende desarrollar nuevas opciones para el tratamiento del
#CáncerdeMama
metastásico, para lo que estudiará la relación entre la metástasis y la vascularización.
1
4
1
reposted by
Gomis
IRB Barcelona
9 months ago
💬Mesa Redonda: Presente y Futuro del #CáncerDeMama 🗣️Dr.
@rgergom.bsky.social
(
@irbbarcelona.org
) 🗣️Dr. César Serrano (Hospital Vall d'Hebron-
@vhio.bsky.social
) 🗣️Carme Segura, paciente cáncer de mama 🎙️Modera: Michele Catanzaro 🗓️Miérc, 5 de febrero 🕡 18:30-20:00h 📍
@iec.cat
🔗
https://bit.ly/3Wx0Fw5
0
2
1
reposted by
Gomis
Marcos Malumbres
12 months ago
Exciting news in cancer therapy! The order of drugs impacts the duration of treatment, toxicity, and economic cost. A necessary example of how relevant academic, self-funded trials are!! Breast
#cancer
#oncosky
#oncsky
#medsky
🧪
@natureportfolio.bsky.social
www.nature.com/articles/d41...
loading . . .
Toxicity and costs of cancer treatment reduced by deferring CDK4/6 inhibitor use
No difference in survival outcomes between use of CDK4/6 inhibitors as first- or second-line treatment in metastatic breast cancer.
https://www.nature.com/articles/d41586-024-03838-9
1
56
17
reposted by
Gomis
IRB Barcelona
12 months ago
🔵 The
#IRBBarcelona
Growth Control &
#Cancer
#Metastasis
lab, led by
@rgergom.bsky.social
is offering two 3-year
#PhD
#fellowships
in the framework of the Adaptmet Project for young scientists community who wish to undertake a doctoral degree in
#biomedicine
. Read more here ➡️
shorturl.at/MDX95
0
4
3
Terrific talk by
@mmalumbres.bsky.social
!! at the biomed conference in barcelona
12 months ago
0
4
1
reposted by
Gomis
Marcos Malumbres
12 months ago
Let’s get started: BioMed Conference on “Mechanisms of resistance in cancer”. Francesc Posas, director of the IRB Barcelona, introducing the event!
#oncosky
🧪
2
8
2
reposted by
Gomis
Marcos Malumbres
12 months ago
Just one day left for the
#BarcelonaBiomed
Conference "Molecular Determinants of
#Cancer
Therapy Resistance"! 🗓️ 18-20 Nov, 2024
#Barcelona
🤝 Angel R Nebreda (#IRB), Clare Isake (ICR_London) &
@mmalumbres.bsky.social
(VHIO), with
@batllelab.bsky.social
and a long list of speakers. ➡️bit.ly/4dBTSYI
0
26
10
reposted by
Gomis
Marcos Malumbres
12 months ago
Cancer cell biologists in the 2024 meeting of the Spanish Association of Cancer Research (ASEICA) in beautiful Zaragoza.. waiting for you guys here in
@bsky.app
1
8
1
reposted by
Gomis
Marcos Malumbres
12 months ago
Historical alliance between Spanish associations against
#cancer
… ASEICA and AECC ContraCancer… we need you in
@bsky.app
1
7
4
you reached the end!!
feeds!
log in
